Voyager Space’s subsidiary Starlab Space has entered into a strategic collaboration with Auxilium Biotechnologies to conduct life sciences experiments in microgravity aboard the planned Starlab commercial station. The agreement encompasses regenerative medicine and drug discovery assays utilizing Auxilium’s biotech capabilities and Starlab’s modular research infrastructure.

The partnership could establish a recurring revenue stream through payload services and laboratory leasing on Starlab once operational. It also positions Voyager Space as a key facilitator of commercial biomedical research in low-Earth orbit, enhancing the company’s value proposition to investors and customers.